The hemodialysis and peritoneal dialysis market in North America is expected to grow from US$ 31,852.39 million in 2022 to US$ 45,277.56 million by 2028; it is estimated to grow at a CAGR of 6.0% from 2022 to 2028.
The rising prevalence of kidney diseases is the major factor driving the North America hemodialysis and peritoneal dialysis market. Chronic kidney disease (CKD) and acute kidney injury (AKI) are conditions in which the kidneys are damaged and cannot filter blood properly. Because of this, excess fluid and waste from blood remain in the body, which may cause other health problems such as heart disease and stroke. CKD usually worsens over time, even though treatment has shown slow progression. If CKD is left untreated, it can progress to kidney failure and early cardiovascular disease. In CKD, when the kidneys stop working, dialysis or kidney transplant is needed for survival. When treated with dialysis or kidney transplant, this kidney failure is called end-stage renal disease (ESRD). According to the Centers for Disease Control and Prevention (CDC), approximately 36 million adults are suffering from CKD in the US. Further, every 24 hours, 360 people begin dialysis treatment for kidney failure. In 2017, 697.5 million cases of CKD (all stages) were recorded worldwide, with a North American prevalence of 9.1%.
In the past few years, the requirement for dialysis has increased. For instance, according to the National Kidney Foundation, in 2018, 785,883 US residents faced kidney failure, of which 554,038 received dialysis. Likewise, according to the data published by the Food & Drug Administration (FDA), about 10,000 children in the US develop AKI. These children have a survival rate of around 38% to 43%.
The increasing prevalence of ESRD is also one of the major factors driving the market. For instance, according to the United States Renal Data System (USRDS), nearly 786,000 people in the country are living with end-stage kidney disease (ESKD), also known as end-stage renal disease (ESRD). Thus, the increasing prevalence of chronic kidney disease, acute kidney injury, and end-stage renal disease, which leads to the condition of dialysis, is driving the hemodialysis and peritoneal dialysis market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America hemodialysis and peritoneal dialysis market. The North America hemodialysis and peritoneal dialysis market is expected to grow at a good CAGR during the forecast period.
North America Hemodialysis and Peritoneal DialysisMarket Revenue and Forecast to 2028 (US$ Million)
North America Hemodialysis and Peritoneal Dialysis Market Segmentation
The North America hemodialysis and peritoneal dialysis market is segmented into type, product, end user, and country. Based on type, the market is bifurcated into hemodialysis and peritoneal dialysis. In 2022, the hemodialysis segment is expected to hold a larger market share. Based on product, the hemodialysis and peritoneal dialysis market is segmented into devices, consumables, and services. The services segment is likely to hold the largest market share in 2022. Based on end user, the market is segmented into hospital-based and home-based. The hospital-based segment is expected to account for a larger share in 2022. Based on country, the North America hemodialysis and peritoneal dialysis market is segmented into the US, Canada, and Mexico. The US is anticipated to hold the largest market share in 2022.
Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International Inc.; DaVita Inc.; Dialife SA; Evoqua Water Technologies LLC. (Mar Cor Purification); Fresenius Medical Care AG & Co KGaA; Nipro Medical Corporation; and Rockwell Medical, Inc. are among the leading companies operating in the North America hemodialysis and peritoneal dialysis market.
The List of Companies - North America Hemodialysis and Peritoneal Dialysis Market
● Asahi Kasei Medical Co., Ltd.
● B. Braun Melsungen AG
● Baxter International Inc.
● DaVita Inc.
● Dialife SA
● Evoqua Water Technologies LLC. (Mar Cor Purification)
● Fresenius Medical Care AG & Co KGaA
● Nipro Medical Corporation
● Rockwell Medical, Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Hemodialysis and Peritoneal Dialysis Market – By Type
1.3.2 North America Hemodialysis and Peritoneal Dialysis Market – By Product
1.3.3 North America Hemodialysis and Peritoneal Dialysis Market – By End User
1.3.4 North America Hemodialysis and Peritoneal Dialysis Market – By Country
2. North America Hemodialysis and Peritoneal Dialysis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Hemodialysis and Peritoneal Dialysis Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Hemodialysis and Peritoneal Dialysis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Kidney Diseases
5.1.2 Increasing Cases of Diabetes
5.2 Market Restraints
5.2.1 Risks and Complications with Dialysis
5.3 Market Opportunities
5.3.1 Surge in Preference of Patients for Home Care Dialysis
5.4 Future Trends
5.4.1 Market Strategies by Major Players
5.5 Impact Analysis
6. Haemodialysis and Peritoneal Dialysis Market– North America Analysis
6.1 North America Haemodialysis and Peritoneal Dialysis Market Revenue Forecast and Analysis
6.2 North America Haemodialysis and Peritoneal Dialysis Market, By Country - Forecast and Analysis
7. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028– by Type
7.1 Overview
7.2 North America Haemodialysis and Peritoneal Dialysis Market, By Type, 2022 & 2028 (%)
7.3 Haemodialysis
7.3.1 Overview
7.3.2 Haemodialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Peritoneal Dialysis
7.4.1 Overview
7.4.2 Peritoneal Dialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
8. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 – Product
8.1 Overview
8.2 North America Haemodialysis and Peritoneal Dialysis Market Share by Product Segment - 2021 & 2028 (%)
8.3 Devices
8.3.1 Overview
8.3.2 Devices: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
8.4 Consumables
8.4.1 Overview
8.4.2 Consumables: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
8.5 Services
8.5.1 Overview
8.5.2 Services: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
9. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 North America Haemodialysis and Peritoneal Dialysis Market Share by End User Segment - 2021 & 2028 (%)
9.3 Hospital-Based
9.3.1 Overview
9.3.2 Hospital-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
9.4 Home-Based
9.4.1 Overview
9.4.2 Home-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 North America: Haemodialysis and Peritoneal Dialysis Market, by Country, 2022 & 2028 (%)
10.1.1.1 US: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 US: Haemodialysis and Peritoneal Dialysis Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.4 US: Haemodialysis and Peritoneal Dialysis Market, by Product, 2019–2028 (US$ Million)
10.1.1.1.5 US: Haemodialysis and Peritoneal Dialysis Market, by End User, 2019–2028 (US$ Million)
10.1.1.2 Canada: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Canada: Haemodialysis and Peritoneal Dialysis Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.4 Canada: Haemodialysis and Peritoneal Dialysis Market, by Product, 2019–2028 (US$ Million)
10.1.1.2.5 Canada: Haemodialysis and Peritoneal Dialysis Market, by End User, 2019–2028 (US$ Million)
10.1.1.3 Mexico: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Mexico: Haemodialysis and Peritoneal Dialysis Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.4 Mexico: Haemodialysis and Peritoneal Dialysis Market, by Product, 2019–2028 (US$ Million)
10.1.1.3.5 Mexico: Haemodialysis and Peritoneal Dialysis Market, by End User, 2019–2028 (US$ Million)
11. Hemodialysis and Peritoneal Dialysis Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Hemodialysis and Peritoneal Dialysis Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Fresenius Medical Care AG & Co KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 DaVita Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Baxter International Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 B. Braun Melsungen AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nipro Medical Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Evoqua Water Technologies LLC. (Mar Cor Purification)
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Asahi Kasei Medical Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Rockwell Medical, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Dialife SA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
